Cowen And Company, LLC Acadia Pharmaceuticals Inc Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $85,981 - $138,727	-5,121 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $80,809 - $126,847	5,121 New	5,121 $85,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $27.42 $145,500 - $205,650	-7,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$25.02 - $54.99 $187,650 - $412,425	7,500 New	7,500 $194,000
Q4 2020 Feb 08, 2021	SELL	$41.04 - $56.79 $58,153 - $80,471	-1,417 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$36.42 - $57.0 $51,607 - $80,769	1,417 New	1,417 $58,000

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.75B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.